Showing results (71-80 of 420) with videos related to
Sort By:
Pageof 42
European Journal of Clinical Pharmacology|January 1, 1981
The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administrationU Gundert-Remy, E Weber, G Lam, et al.Zeitschrift Fur Gastroenterologie|April 1, 1989
Plasma clearance of bile acids in the rat: hepatic uptake under physiological conditions without countertransportU Gärtner, U Gundert-Remy, A Stiehl, et al.Archives of Toxicology|March 31, 2000
CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicalsU Bernauer, B Vieth, R Ellrich, et al.Digestion|January 1, 1983
Hepatic secretion of bilirubin and biliary lipids in patients with alcoholic cirrhosis of the liverR Raedsch, A Stiehl, U Gundert-Remy, et al.European Journal of Clinical Pharmacology|August 1, 1979
Plasma and urinary levels of triamterene and certain metabolites after oral administration to manU Gundert-Remy, D von Kenne, E Weber, et al.Acta Anaesthesiologica Scandinavica|August 1, 1997
Pharmacodynamic modelling of the analgesic effects of piritramide in postoperative patientsD Kietzmann, T Bouillon, C Hamm, et al.Archives of Toxicology|August 27, 1999
CYP2E1-dependent benzene toxicity: the role of extrahepatic benzene metabolismU Bernauer, B Vieth, R Ellrich, et al.Schmerz (Berlin, Germany)|October 22, 2016
[Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis]U M Stamer, U Gundert-Remy, E Biermann, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1996
Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranesS V Löser, J Meyer, S Freudenthaler, et al.Journal of Neural Transmission. Supplementum|January 1, 1994
Adenosine--an endogenous neuroprotective metabolite and neuromodulatorJ Deckert, C H GleiterPageof 42